Full Text View
Tabular View
No Study Results Posted
Related Studies
Immunogenicity and Safety Study of FSME-IMMUN 0.5 mL in Adult Subjects Previously Vaccinated According to a Rapid Immunization Schedule
This study has been completed.
Study NCT00460486   Information provided by Baxter Healthcare Corporation
First Received: April 13, 2007   Last Updated: March 27, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Encephalitis, Tick-Borne
Additional conditions recognized in this trial
Encephalitis
More general conditions related to this trial
Arbovirus Infections
Brain Diseases
Central Nervous System Diseases
Central Nervous System Infections
Central Nervous System Viral Diseases
Encephalitis, Arbovirus
Encephalitis, Viral
Flaviviridae Infections
Flavivirus Infections
Nervous System Diseases
RNA Virus Infections
Tick-Borne Diseases
Virus Diseases
Additional drug interventions recognized in this trial
Formaldehyde
More general drug interventions related to this trial
Anti-Infective Agents
Disinfectants
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Baxter Healthcare Corporation


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services